First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)

Citation metadata

From: Journal of Infectious Diseases(Vol. 207, Issue 2)
Publisher: University of Chicago Press
Document Type: Clinical report

Document controls

Main content

Source Citation

Source Citation   

Gale Document Number: GALE|A341141472